Verastem (VSTM) Receivables (2018 - 2026)
Verastem's (VSTM) quarterly Receivables came in at $10.2 million in Q1 2026, up 15.26% quarter-over-quarter from $8.8 million in Q4 2025.
Verastem (VSTM) Receivables (2018 - 2026) Analysis & Trends
Verastem's Receivables history runs 9 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- On a quarterly basis, Receivables changed N/A year-over-year to $10.2 million in Q1 2026; TTM through Mar 2026 was $10.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.8 million, changed N/A from the prior year.
- Receivables rose to $10.2 million in Q1 2026 per VSTM's latest filing, from $8.8 million in the prior quarter.
- Across five years, Receivables topped out at $10.2 million in Q1 2026 and bottomed at $31000.0 in Q4 2022.
- The 5-year median for Receivables is $200000.0 (2022), against an average of $3.2 million.
- Across the five-year window, Receivables plunged 97.66% in 2023 and jumped 16029.03% in 2024, its largest moves.
- Year by year, Receivables stood at $31000.0 in 2022, then jumped by 35.48% to $42000.0 in 2023, then soared by 23709.52% to $10.0 million in 2024, then slipped by 11.87% to $8.8 million in 2025, then grew by 15.26% to $10.2 million in 2026.
- Per Business Quant, the three latest VSTM Receivables figures stand at $10.2 million (Q1 2026), $8.8 million (Q4 2025), and $6.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | 10.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.16 Mn |
| Dec 31, 2025 | 8.81 Mn |
| Sep 30, 2025 | 6.72 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 42,000.00 |
| Jun 30, 2023 | 62,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 31,000.00 |
| Sep 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 170,000.00 |
| Sep 30, 2021 | 130,000.00 |
| Jun 30, 2021 | 476,000.00 |
| Mar 31, 2021 | 1.13 Mn |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 5.69 Mn |
| Jun 30, 2020 | 1.50 Mn |